iPhone app iPad app Android phone app Android tablet app

Big Pharma

CNN's Gupta: Not What the Doctor Ordered

James Floyd, M.D. | Posted 05.25.2011 | Politics
James Floyd, M.D.

Gupta downplays safety risks in treatments, and was criticized for his reporting on Vioxx, a pain medication that was withdrawn from the market in 2004 because it causes heart attacks.

Innovations in Phase IV Clinical Trials for Change in Health Care

Sunil Chacko | Posted 05.25.2011 | Politics
Sunil Chacko

For dying patients with no therapy that is working, compassionate use programs exist to provide drugs in phase II or III clinical trials when the patient was ineligible to participate in the trial.

Pfizer To Buy Wyeth For $68 Billion

AP | LINDA A. JOHNSON | Posted 05.25.2011 | Business

TRENTON, N.J. — Pfizer Inc., the world's largest drugmaker, said Monday it is buying rival Wyeth for $68 billion in a deal that will quickly boo...

Pfizer, Wyeth In Talks For $60B Merger

Wall Street Journal | MATTHEW KARNITSCHNIG and JONATHAN D. ROCKOFF | Posted 05.25.2011 | Business

Pfizer Inc. is in talks to acquire rival drug maker Wyeth in a deal that could be valued at more than $60 billion, said people familiar with the matte...

Just How Corrupted Has American Medicine Become?

Bruce E. Levine | Posted 05.25.2011 | Business
Bruce E. Levine

Drug-company corruption of American medicine is of course not news. What is news is that such corruption has become so egregious, so transparent, and so embarrassing.

A New Year's Resolution for the FDA: Kick the Drug (Company) Addiction

Jeanne Lenzer and Shannon Brownlee | Posted 05.25.2011 | Politics
Jeanne Lenzer and Shannon Brownlee

The FDA needs to admit that it is currently powerless over the industry it is supposed to be regulating; it has let Big Pharma take over and become dependent on drug company money.

Healthcare Abducted

Dr. Jeffrey McCombs | Posted 11.17.2011 | Healthy Living
Dr. Jeffrey McCombs

Mainstream healthcare in America has been abducted by the pharmaceutical and insurance companies. As profits have moved to the center stage, patient c...

Pfizer Reaches Massive Settlement In Celebrex, Bextra Lawsuits

AP | LINDA A. JOHNSON | Posted 05.25.2011 | Business

TRENTON, N.J. — Drug giant Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bext...

Counterfeit Democracy

Robert Weissman | Posted 05.25.2011 | Business
Robert Weissman

A new draft global trade treaty may interfere with fair use of copyrighted materials, require Internet Service Providers (ISPs) to monitor all consume...

Doctors, Nutritionists and Jewish Geography

Dr. Jonny Bowden | Posted 11.17.2011 | Healthy Living
Dr. Jonny Bowden

Doctors know as much about nutrition, diet, supplements and exercise as Portuguese language professors know about agility training for the Portuguese Water Dog.

From FDA to GSK: The Dangerous Partnership between Government and Big Pharma

Dr. Peter Breggin | Posted 05.25.2011 | Politics
Dr. Peter Breggin

The FDA is not so much a watchdog agency as an active member of the psychopharmaceutical complex working on behalf on the drug industry.

Congress Pummels Establishment Psychiatry but Neglects a Brave Psychiatrist

Bruce E. Levine | Posted 11.17.2011 | Healthy Living
Bruce E. Levine

The corruption of psychiatry by Big Pharma has resulted in the suppression of effective treatment options and has marginalized courageous, innovative, and non-corrupt psychiatrists.

Mental Recession: Like Manna From Heaven

Liz Spikol | Posted 05.25.2011 | Politics
Liz Spikol

As a mental health journalist and someone who suffers with bipolar disorder, if there's one thing I know, it's how to solve a "mental" crisis.

Why I'm Not Convinced Big Pharma Is Behind Pot Prohibition (But That's Not to Say They Aren't Looking to Cash in on Medical Marijuana)

Paul Armentano | Posted 05.25.2011 | Politics
Paul Armentano

At the same time that federal lawmakers are proclaiming that pot has no medical value, Big Pharma is in a frenzy to bring dozens of new, cannabis-based medicines to market.

Pfizer May Get Into Bidding For Ranbaxy, Generic Drug Maker

Reuters | Posted 05.25.2011 | Business

MUMBAI (Reuters) - Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion (2.4 billion pound) offer by Japan's Daiichi Sankyo for the Indi...

Pfizer Skin Cancer Drug Fails Clinical Test

Wall Street Journal | Scott Hensley | Posted 05.25.2011 | Business

Pfizer's search for new drugs took another hit when the company halted a late-stage trial of an experimental medicine to treat metastatic skin cancer....

Pfizer Pulls Misleading Lipitor Ads

New York TImes | Stephanie Saul | Posted 05.25.2011 | Business

Under criticism that its ads are misleading, Pfizer said Monday that it would cancel a long-running advertising campaign using the artificial heart pi...

Big Pharma Raised Top Drug Prices By 7.8 Percent In 2007

Wall Street Journal | HEATHER WON TESORIERO | Posted 05.25.2011 | Business

The pharmaceutical industry has been a frequent target in the current presidential campaign, but that hasn't stopped it from continuing to aggressivel...

Overmedication Nation

The New York Times | Judith Warner | Posted 11.17.2011 | Healthy Living

This storyline persists despite the fact that government research has repeatedly shown that most adults and children with mental health issues don't g...

Merck Settles With Govt Over Rebates

AP | LINDA A. JOHNSON | Posted 05.25.2011 | Business

TRENTON, N.J. — In one of the biggest U.S. health care fraud settlements ever, Merck & Co. will pay $671 million to settle claims it overcharged...

Wyeth Sues Teva Over Heartburn Drug

AP | DAMIAN J. TROISE | Posted 05.25.2011 | Business

A patent dispute over the heartburn drug Protonix escalated Monday when Wyeth said it will sue to recover lost profits from sales of Teva Pharmaceutic...

Eli Lilly Appoints New CEO

AP | Posted 05.25.2011 | Business

The drugmaker Eli Lilly and Co. said Tuesday Sidney Taurel will retire as chief executive on March 31 after nearly a decade in the post and will step ...

Novartis To Cut 2,500 Jobs

AP | Posted 05.25.2011 | Business

Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 billion, the drug maker said Thursday. The company said it would take a ...

Big Pharma Frets As Major Patent Expirations Loom

Wall Street Journal | BARBARA MARTINEZ, JACOB GOLDSTEIN | Posted 05.25.2011 | Business

Over the next few years, the pharmaceutical business will hit a wall. Some of the top-selling drugs in industry history will become history as patent...

Bristol-Myers To Cut 4,300 Jobs

BBC News | Posted 05.25.2011 | Business

US drugmaker Bristol-Myers Squibb says it will cut its 43,000-strong workforce by 10% and close half of its 27 manufacturing plants to save $1.5bn. T...